Omega Fund Management »

Lexeo Therapeutics shares owned by Omega Fund Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Omega Fund Management from 13F filings

Historical chart of Omega Fund Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Omega Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Omega Fund Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $38M 2.4M 16.04
2024-03-31 $37M 2.4M 15.68
2023-12-31 $29M 2.2M 13.42

More positions owned by Omega Fund Management

Nuvation Bio Common Stock Class A (NUVB)
Lexeo Therapeutics Common Stock (LXEO)
Replimune Group Common Stock (REPL)
enGene Holdings Common Stock (ENGN)
Alumis Common Stock (ALMS)
Morphic Holding Common Stock (MORF)
Sana Biotechnology Common Stock (SANA)
Ikena Oncology Common Stock (IKNA)
Immunic Common Stock (IMUX)
Syros Pharmaceuticals Common Stock (SYRS)
enGene Holdings Warrant (ENGNW)

View all positions for Omega Fund Management

Top funds holding Lexeo Therapeutics

Henderson Group
Citadel Advisors
Omega Fund Management
Eventide Asset Management
BlackRock
Frazier Life Sciences Management
Blackstone Group
Novo A/S
Woodline Partners
Vestal Point Capital
BlackRock
Braidwell
Vanguard Group
Siren
Geode Capital Management

View all funds holding Lexeo Therapeutics